Table 5. Rate of IE according to predisposing heart disease and setting of acquisition.
| Setting of acquisition | Predisposing heart disease | Total | ||
|---|---|---|---|---|
| Yes, prosthetic | Yes, native | No | ||
| Community associated—intravenous drug use | 2/2 (100%) | 1/3 (33.3%) | 18/38 (47.4%) | 21/43 (48.8%) |
| Community associated—non intravenous drug use | 20/30 (66.7%) | 31/80 (38.8%) | 35/369 (9.5%) | 86/479 (18.0%) |
| Non-nosocomial healthcare associated | 6/13 (46.2%) | 15/66 (22.7%) | 21/274 (7.7%) | 42/353 11.9% |
| Nosocomial | 18/94 (19.1%) | 20/191 (10.5%) | 31/790 (3.9%) | 69/1075 (6.4%) |
| Unknown | 0/1 (0%) | 2/10 (20%) | 1/47 (2.1%) | 3/58 (5.2%) |
| Total | 46/140 (32.9%) | 69/350 (19.7%) | 106/1518 (7%) | 221/2008 (11%) |